/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

G

Gun Almqvist

AstraZeneca (Finland)(FI)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

39

Papers

1.7K

Citations

14

h-index

14

i10-index

Gun Almqvist is an academic researcher from AstraZeneca (Finland). The author has contributed to research in topics: Asthma and respiratory diseases & Allergic Rhinitis and Sensitization & Respiratory and Cough-Related Research. The author has an h-index of 14, co-authored 34 publications.

Research Topics

Asthma and respiratory diseases Allergic Rhinitis and Sensitization Respiratory and Cough-Related Research Chronic Obstructive Pulmonary Disease (COPD) Research Dermatology and Skin Diseases

Papers by this author

works

Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma

2021 · New England Journal of Medicine · 884 citations

https://doi.org/10.1056/nejmoa2034975

Andrew Menzies‐Gow Jonathan Corren Arnaud Bourdin Geoffrey Chupp

NAVIGATOR: a phase 3 multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the efficacy and safety of tezepelumab in adults and adolescents with severe, uncontrolled asthma

2020 · Respiratory Research · 108 citations

https://doi.org/10.1186/s12931-020-01526-6

Andrew Menzies‐Gow Gene Colice Janet M. Griffiths Gun Almqvist

SOURCE: a phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel group trial to evaluate the efficacy and safety of tezepelumab in reducing oral corticosteroid use in adults with oral corticosteroid dependent asthma

2020 · Respiratory Research · 86 citations

https://doi.org/10.1186/s12931-020-01503-z

Michael E. Wechsler Gene Colice Janet M. Griffiths Gun Almqvist

Efficacy and safety of tezepelumab versus placebo in adults with moderate to very severe chronic obstructive pulmonary disease (COURSE): a randomised, placebo-controlled, phase 2a trial

2024 · The Lancet Respiratory Medicine · 54 citations

https://doi.org/10.1016/s2213-2600(24)00324-2

Dave Singh Christopher E. Brightling Klaus F. Rabe MeiLan K Han

Repeated intranasal TLR7 stimulation reduces allergen responsiveness in allergic rhinitis

2012 · Respiratory Research · 50 citations

https://doi.org/10.1186/1465-9921-13-53

Lennart Greiff Anders Cervin Cecilia Ahlström‐Emanuelsson Gun Almqvist

MOESM1 of Effects of the Toll-like receptor 7 (TLR7) agonist, AZD8848, on allergen-induced responses in patients with mild asthma: a double-blind, randomised, parallel-group study

2019 · Figshare · 0 citations

https://doi.org/10.6084/m9.figshare.11414823

Brian Leaker Dave Singh S. Lindgren Gun Almqvist

Research topics

topics

Asthma and respiratory diseases

Allergic Rhinitis and Sensitization

Respiratory and Cough-Related Research

Chronic Obstructive Pulmonary Disease (COPD) Research

Dermatology and Skin Diseases

Chat about Author

Papers

Chat

Click to start Chat